Self-reported Impact of the Early 2020 COVID-19 Crisis on the Healthcare Pathway During and After Lockdown in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Practical Survey

Authors: Jessica Nasseh MD, Céline Podevin MMed, Camille Ternynck PhD, Hélène Zephir MD, PhD, Jean-Guillaume Letarouilly MD, René-Marc Flipo MD, PhD, Maria Nachury MD, Cécile Chenivesse MD, PhD, Eric Hachulla MD, PhD, David Launay MD, PhD, Delphine Staumont-Salle MD, PhD, Frédéric Dezoteux MD

Source: Journal of Patient Experience, Vol 9 (2022)

Subject Terms: Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/2374-3743

Access URL: https://doaj.org/article/02cae71fdd174d0eaaa4d25cfc96b2bf

Pyoderma gangrenosum developing in a patient treated with dupilumab

Authors: Jessica Nasseh, MD, Henry Abi Rached, MD, Ioana Dumitru, MD, Delphine Staumont-Sallé, MD, PhD, Frédéric Dezoteux, MD

Source: JAAD Case Reports, Vol 20, Iss , Pp 58-60 (2022)

Subject Terms: atopic dermatitis, drug reaction, dupilumab, pyoderma gangrenosum, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352512621009097; https://doaj.org/toc/2352-5126

Access URL: https://doaj.org/article/54739df8eaaa4523885eb4a1d9a12b6a